MannKind Corporation Announces Participation at Upcoming Conferences
March 04 2024 - 1:01PM
MannKind Corporation (Nasdaq: MNKD), a company
focused on the development and commercialization of inhaled
therapeutic products and devices for patients with endocrine and
orphan lung diseases, announced today that it will be participating
at upcoming conferences.
- Leerink Partners Global Biopharma Conference 2024 – Investor
Meetings, Monday, March 11, 2024
- Oppenheimer 34th Annual Healthcare MedTech & Services
Conference – Corporate Presentation, Wednesday, March 13, 2024 at
9:20 am (ET) and Investor Meetings
Interested parties can access a link to the live webcast of the
presentation from the Events & Presentations section of the
Company’s website at
https://investors.mannkindcorp.com/events-and-presentations. The
webcast replay may be accessed at the same location for 14 days
following the live presentation.
About MannKind
MannKind Corporation (Nasdaq: MNKD) focuses on the development
and commercialization of innovative therapeutic products and
devices to address serious unmet medical needs for those living
with endocrine and orphan lung diseases.
We are committed to using our formulation capabilities and
device engineering prowess to lessen the burden of diseases such as
diabetes, pulmonary arterial hypertension (PAH) and nontuberculous
mycobacterial (NTM) lung disease. Our signature technologies –
dry-powder formulations and inhalation devices – offer rapid and
convenient delivery of medicines to the deep lung where they can
exert an effect locally or enter the systemic circulation.
With a passionate team of Mannitarians collaborating nationwide,
we are on a mission to give people control of their health and the
freedom to live life.
Please visit mannkindcorp.com to learn more, and follow us on
LinkedIn, Facebook, Twitter or Instagram.
MannKind Contact:Rose Alinaya, Investor
Relations(818) 661-5000Email: ir@mannkindcorp.com
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Jun 2024 to Jul 2024
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Jul 2023 to Jul 2024